Global Recombinant DNA Technology Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
• 1.4 Market by Type
  • 1.4.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Therapeutic Agent
  • 1.4.3 Vaccine
  • 1.4.4 Biotech Crops
  • 1.4.5 Specialty Chemicals
• 1.5 Market by Application
  • 1.5.1 Global Recombinant DNA Technology Market Share by Application: 2020 VS 2026
  • 1.5.2 Biotechnology and Pharmaceutical Companies
  • 1.5.3 Academic & Government Research Institutes
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Recombinant DNA Technology Market Perspective (2015-2026)
• 2.2 Global Recombinant DNA Technology Growth Trends by Regions
  • 2.2.1 Recombinant DNA Technology Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Recombinant DNA Technology Historic Market Share by Regions (2015-2020)
  • 2.2.3 Recombinant DNA Technology Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Recombinant DNA Technology Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Recombinant DNA Technology Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Recombinant DNA Technology Players by Market Size
  • 3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2015-2020)
  • 3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Recombinant DNA Technology Market Concentration Ratio
  • 3.2.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2019
• 3.3 Recombinant DNA Technology Key Players Head office and Area Served
• 3.4 Key Players Recombinant DNA Technology Product Solution and Service
• 3.5 Date of Enter into Recombinant DNA Technology Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Recombinant DNA Technology Historic Market Size by Type (2015-2020)
• 4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Recombinant DNA Technology Market Size by Application (2015-2020)
• 5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Recombinant DNA Technology Market Size (2015-2020)
• 6.2 Recombinant DNA Technology Key Players in North America (2019-2020)
• 6.3 North America Recombinant DNA Technology Market Size by Type (2015-2020)
• 6.4 North America Recombinant DNA Technology Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Recombinant DNA Technology Market Size (2015-2020)
• 7.2 Recombinant DNA Technology Key Players in Europe (2019-2020)
• 7.3 Europe Recombinant DNA Technology Market Size by Type (2015-2020)
• 7.4 Europe Recombinant DNA Technology Market Size by Application (2015-2020)

8 China

• 8.1 China Recombinant DNA Technology Market Size (2015-2020)
• 8.2 Recombinant DNA Technology Key Players in China (2019-2020)
• 8.3 China Recombinant DNA Technology Market Size by Type (2015-2020)
• 8.4 China Recombinant DNA Technology Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Recombinant DNA Technology Market Size (2015-2020)
• 9.2 Recombinant DNA Technology Key Players in Japan (2019-2020)
• 9.3 Japan Recombinant DNA Technology Market Size by Type (2015-2020)
• 9.4 Japan Recombinant DNA Technology Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Recombinant DNA Technology Market Size (2015-2020)
• 10.2 Recombinant DNA Technology Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Recombinant DNA Technology Market Size by Type (2015-2020)
• 10.4 Southeast Asia Recombinant DNA Technology Market Size by Application (2015-2020)

11 India

• 11.1 India Recombinant DNA Technology Market Size (2015-2020)
• 11.2 Recombinant DNA Technology Key Players in India (2019-2020)
• 11.3 India Recombinant DNA Technology Market Size by Type (2015-2020)
• 11.4 India Recombinant DNA Technology Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Recombinant DNA Technology Market Size (2015-2020)
• 12.2 Recombinant DNA Technology Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Recombinant DNA Technology Market Size by Type (2015-2020)
• 12.4 Central & South America Recombinant DNA Technology Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Monsanto Company
  • 13.1.1 Monsanto Company Company Details
  • 13.1.2 Monsanto Company Business Overview
  • 13.1.3 Monsanto Company Recombinant DNA Technology Introduction
  • 13.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2015-2020))
  • 13.1.5 Monsanto Company Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview
  • 13.2.3 Roche Recombinant DNA Technology Introduction
  • 13.2.4 Roche Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Biogen
  • 13.3.1 Biogen Company Details
  • 13.3.2 Biogen Business Overview
  • 13.3.3 Biogen Recombinant DNA Technology Introduction
  • 13.3.4 Biogen Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.3.5 Biogen Recent Development
• 13.4 Amgen
  • 13.4.1 Amgen Company Details
  • 13.4.2 Amgen Business Overview
  • 13.4.3 Amgen Recombinant DNA Technology Introduction
  • 13.4.4 Amgen Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.4.5 Amgen Recent Development
• 13.5 Novartis
  • 13.5.1 Novartis Company Details
  • 13.5.2 Novartis Business Overview
  • 13.5.3 Novartis Recombinant DNA Technology Introduction
  • 13.5.4 Novartis Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.5.5 Novartis Recent Development
• 13.6 Eli Lilly and Company
  • 13.6.1 Eli Lilly and Company Company Details
  • 13.6.2 Eli Lilly and Company Business Overview
  • 13.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
  • 13.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.6.5 Eli Lilly and Company Recent Development
• 13.7 GenScript
  • 13.7.1 GenScript Company Details
  • 13.7.2 GenScript Business Overview
  • 13.7.3 GenScript Recombinant DNA Technology Introduction
  • 13.7.4 GenScript Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.7.5 GenScript Recent Development
• 13.8 Pfizer Inc.
  • 13.8.1 Pfizer Inc. Company Details
  • 13.8.2 Pfizer Inc. Business Overview
  • 13.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
  • 13.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.8.5 Pfizer Inc. Recent Development
• 13.9 Novo Nordisk
  • 13.9.1 Novo Nordisk Company Details
  • 13.9.2 Novo Nordisk Business Overview
  • 13.9.3 Novo Nordisk Recombinant DNA Technology Introduction
  • 13.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.9.5 Novo Nordisk Recent Development
• 13.10 Sanofi
  • 13.10.1 Sanofi Company Details
  • 13.10.2 Sanofi Business Overview
  • 13.10.3 Sanofi Recombinant DNA Technology Introduction
  • 13.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2015-2020)
  • 13.10.5 Sanofi Recent Development
• 13.11 Merck KGaA
  • 10.11.1 Merck KGaA Company Details
  • 10.11.2 Merck KGaA Business Overview
  • 10.11.3 Merck KGaA Recombinant DNA Technology Introduction
  • 10.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.11.5 Merck KGaA Recent Development
• 13.12 Profacgen
  • 10.12.1 Profacgen Company Details
  • 10.12.2 Profacgen Business Overview
  • 10.12.3 Profacgen Recombinant DNA Technology Introduction
  • 10.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.12.5 Profacgen Recent Development
• 13.13 Biocon
  • 10.13.1 Biocon Company Details
  • 10.13.2 Biocon Business Overview
  • 10.13.3 Biocon Recombinant DNA Technology Introduction
  • 10.13.4 Biocon Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.13.5 Biocon Recent Development
• 13.14 GlaxoSmithKline
  • 10.14.1 GlaxoSmithKline Company Details
  • 10.14.2 GlaxoSmithKline Business Overview
  • 10.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
  • 10.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.14.5 GlaxoSmithKline Recent Development
• 13.15 Cibus
  • 10.15.1 Cibus Company Details
  • 10.15.2 Cibus Business Overview
  • 10.15.3 Cibus Recombinant DNA Technology Introduction
  • 10.15.4 Cibus Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.15.5 Cibus Recent Development
• 13.16 Horizon Discovery Group
  • 10.16.1 Horizon Discovery Group Company Details
  • 10.16.2 Horizon Discovery Group Business Overview
  • 10.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
  • 10.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.16.5 Horizon Discovery Group Recent Development
• 13.17 New England Biolabs
  • 10.17.1 New England Biolabs Company Details
  • 10.17.2 New England Biolabs Business Overview
  • 10.17.3 New England Biolabs Recombinant DNA Technology Introduction
  • 10.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2015-2020)
  • 10.17.5 New England Biolabs Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer